logo-loader

Proactive events

Proactive One2One Investor Forum

21 October 2021 | London

Virtual

Hearing the inside story and understanding the team behind the performance is crucial to making informed decisions. Join us at our next Proactive event to see leading growth companies make their pitch

Leading companies pitching

1611670627_1609920030529
Redx Pharma PLC

Redx Pharma PLC is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, targeted medicines for the treatment of fibrotic disease, cancer and the emerging area of cancer-associated fibrosis.  

1627118161_er
Ergomed PLC

Ergomed PLC provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. The company's fast-growing services business includes an...

1635914420_Highlight+logo
Highlight Therapeutics

Highlight Therapeutics is a private, clinical-stage company dedicated to unlocking the full potential of immuno-oncology. The company's lead drug candidate BO-112 is a best-in-class RNA-based therapy which has been demonstrated to initiate a...

logo_625e62fc9dfff
Arecor Therapeutics PLC

Arecor Therapeutics PLC is a globally focused biopharmaceutical group transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying its innovative proprietary...

Meet the real story

Join our audience of astute high net worth investors, fund managers, private client brokers and analysts

Look beyond the numbers and meet the people creating the value for shareholders

Each company has a presentation slot followed by Q & A, giving you the chance to discover the real story

Watch the event afterwards on our YouTube channel

Proactive events

The best event for investors looking for the insights that keep you a step ahead of the crowd

See more Proactive events >

One2one investor forums are suitable for sophisticated private investors, private client brokers, fund managers, financial institutions, hedge funds, buy and sell side analysts and journalists. The event is not suitable for people pursuing commercial opportunities.